Overview

A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients

Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
1. OBJECTIVES Primary objective to evaluate the difference of the peak oxygen uptake change (VO2 max, mL/kg/min) in amlodipine group against no CCB group at 9 months Secondary objectives To evaluate the change of sublingual nitrate use per day against no CCB group at 1 and 3 months To evaluate the change of biomarkers against no CCB group at 9 months 2. SUBJECTS AND CENTERS 212, stable angina patients with angiographically confirmed significant residual stenosis 10, 3rd-grade, teaching hospitals in Korea
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Amlodipine